Journal of Cataract & Refractive Surgery
Volume 34, Issue 3 , Pages 505-509 , March 2008

Intracameral antibiotics: Questions for the United States based on prospective studies

  • Thomas J. Liesegang, MD

      Affiliations

    • Corresponding Author InformationCorresponding author: Thomas J. Liesegang, MD, Mayo Clinic, 4500 San Pablo Road South, Jacksonville, Florida 32224, USA.

,Accepted 4 November 2007.

References 

  1. Lundström M, Wejde G, Stenevi U, et al. Endophthalmitis after cataract surgery: a nationwide prospective study evaluating incidence in relation to incision type and location. Ophthalmology. 2007;114:831–832
  2. Wejde G, Samolov B, Seregard S, et al. Risk factors for endophthalmitis following cataract surgery: a retrospective case-control study. J Hosp Infect. 2005;61:251–256
  3. Montan PG, Wejde G, Setterquist H, et al. Prophylactic intracameral cefuroxime; evaluation of safety and kinetics in cataract surgery. J Cataract Refract Surg. 2002;28:982–987
  4. Montan PG, Wejde G, Koranyi G, Rylander M. Prophylactic intracameral cefuroxime; efficacy in preventing endophthalmitis after cataract surgery. J Cataract Refract Surg. 2002;28:977–981
  5. Seal DV, Barry P, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; case for a European multicenter study; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg. 2006;32:396–406
  6. Barry P, Seal DV, Gettinby G, et al. ESCRS study of prophylaxis of postoperative endophthalmitis after cataract surgery; preliminary report of principal results from a European multicenter study; the ESCRS Endophthalmitis Study Group. J Cataract Refract Surg. 2006;32:407–410
  7. ESCRS Endophthalmitis Study Group . Prophylaxis of postoperative endophthalmitis following cataract surgery: results of the ESCRS multicenter study and identification of risk factors. J Cataract Refract Surg. 2007;33:978–988
  8. Ng JQ, Morlet N, Bulsara MK, Semmens JB. Reducing the risk for endophthalmitis after cataract surgery: population-based nested case-control study; Endophthalmitis Population Study of Western Australia sixth report. J Cataract Refract Surg. 2007;33:269–280
  9. Li J, Morlet N, Ng JQ, et al. Significant nonsurgical risk factors for endophthalmitis after cataract surgery: EPSWA fourth report; for Team EPSWA. Invest Ophthalmol Vis Sci. 2004;45:1321–1328Available at: http://www.iovs.org/cgi/reprint/45/5/1321Accessed December 10, 2007
  10. Nagaki Y, Hayasaka S, Kadoi C, et al. Bacterial endophthalmitis after small-incision cataract surgery; effect of incision placement and intraocular lens type. J Cataract Refract Surg. 2003;29:20–26
  11. West ES, Behrens A, McDonnell PJ, et al. The incidence of endophthalmitis after cataract surgery among the U.S. Medicare population increased between 1994 and 2001. Ophthalmology. 2005;112:1388–1394
  12. Taban M, Rao B, Reznik J, et al. Dynamic morphology of sutureless cataract wounds – effect of incision angle and location. Surv Ophthalmol. 2004;49(suppl 2):S62–S72
  13. Moshirfar M, Feiz V, Vitale AT, et al. Endophthalmitis after uncomplicated cataract surgery with the use of fourth-generation fluoroquinolones; a retrospective observational case series. Ophthalmology. 2007;114:686–691
  14. Chang DF, Braga-Mele R, Mamalis N, et al. Prophylaxis of postoperative endophthalmitis after cataract surgery; results of the 2007 ASCRS member survey; the ASCRS Cataract Clinical Committee. J Cataract Refract Surg. 2007;33:1801–1805
  15. Wallin T, Parker J, Jin Y, et al. Cohort study of 27 cases of endophthalmitis at a single institution. J Cataract Refract Surg. 2005;31:735–741
  16. Mamalis N, Edelhauser HF, Dawson DG, et al. Toxic anterior segment syndrome. J Cataract Refract Surg. 2006;32:324–333
  17. Axer-Siegel R, Stiebel-Kalish H, Rosenblatt I, et al. Cystoid macular edema after cataract surgery with intraocular vancomycin. Ophthalmology. 1999;106:1660–1664
  18. Ball JL, Barrett GD. Prospective randomized controlled trial of the effect of intracameral vancomycin and gentamicin on macular retinal thickness and visual function following cataract surgery. J Cataract Refract Surg. 2006;32:789–794
  19. Villada JR, Vicente U, Javaloy J, Alió JL. Severe anaphylactic reaction after intracameral antibiotic administration during cataract surgery. J Cataract Refract Surg. 2005;31:620–621
  20. Gritz DC, Cevallos AV, Smolin G, Whitcher JP. Antibiotic supplementation of intraocular irrigating solutions; an in vitro model of antibacterial action. Ophthalmology. 1996;103:1204–1208discussion by DB Jones, 1208–1209
  21. Espiritu CRG, Caparas VL, Bolinao JG. Safety of prophylactic intracameral moxifloxacin 0.5% ophthalmic solution in cataract surgery patients. J Cataract Refract Surg. 2007;33:63–68
  22. Kowalski RP, Romanowski EG, Mah FS, et al. Intracameral Vigamox® (moxifloxacin 0.5%) is non-toxic and effective in preventing endophthalmitis in a rabbit model. Am J Ophthalmol. 2005;140:497–504
  23. Leaming DV. Snapshots. [guest editorial] J Cataract Refract Surg. 2006;32:1401–1402
  24. Rosha DS, Ng JQ, Morlet N, et al. Cataract surgery practice and endophthalmitis prevention by Australian and New Zealand ophthalmologists. Clin Exp Ophthalmol. 2006;34:535–544
  25. Ashraf KM, Siddique M. Endophthalmitis prophylaxis for cataract surgery: the first Pakistan survey. J Cataract Refract Surg. 2006;32:368
  26. Ang GS, Barras CW. Prophylaxis against infection in cataract surgery: a survey of routine practice. Eur J Ophthalmol. 2006;16:394–400
  27. Dinakaran S, Crome DA. Prophylactic measures prevalent in the United Kingdom. J Cataract Refract Surg. 2002;28:387–388
  28. Gupta MS, McKee HDR, Stewart OG. Perioperative prophylaxis for cataract surgery; survey of ophthalmologists in the north of England. J Cataract Refract Surg. 2004;30:2021–2022
  29. Bratzler DW, Houck PM. Antimicrobial prophylaxis for surgery: an advisory statement from the National Surgical Infection Prevention Project; for the Surgical Infection Prevention Guideline Writers Workgroup. Am J Surg. 2005;189:395–404
  30. Speaker MG, Milch FA, Shah MK, et al. Role of external bacterial flora in the pathogenesis of acute postoperative endophthalmitis. Ophthalmology. 1991;98:639–649discussion by J Baum, 650
  31. Gaál V, Kilár F, Acs B, et al. In vitro study of antibiotic effect on bacterial adherence to acrylic intraocular lenses. Colloids Surf B Biointerfaces. 2005;45:125–130
  32. Olson RJ. Reducing the risk of postoperative endophthalmitis. Surv Ophthalmol. 2004;49(suppl 2):S55–S61
  33. Cooper BA, Holekamp NM, Bohigian G, Thompson PA. Case-control study of endophthalmitis after cataract surgery comparing scleral tunnel and clear cornea wounds. Am J Ophthalmol. 2003;136:300–305
  34. McDonnell PJ, Taban M, Sarayba M, et al. Dynamic morphology of clear corneal cataract incisions. Ophthalmology. 2003;110:2342–2348
  35. Taban M, Behrens A, Newcomb RL, et al. Acute endophthalmitis following cataract surgery; a systematic review of the literature. Arch Ophthalmol. 2005;123:613–620
  36. Speaker MG, Menikoff JA. Prophylaxis of endophthalmitis with topical povidone-iodine. Ophthalmology. 1991;98:1769–1775
  37. Barkana Y, Almer Z, Segal O, et al. Reduction of conjunctival bacterial flora by povidone-iodine, ofloxacin and chlorhexidine in an outpatient setting. Acta Ophthalmol Scand. 2005;83:360–363
  38. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338:339–343
  39. Aly R, Maibach HI. Comparative antibacterial efficacy of a 2-minute surgical scrub with chlorhexidine gluconate, povidone-iodine, and chloroxylenol sponge-brushes. Am J Infect Control. 1988;16:173–177
  40. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136:792–801
  41. Linder N, Prince S, Barzilai A, et al. Disinfection with 10% povidone-iodine versus 0.5% chlorhexidine gluconate in 70% isopropanol in the neonatal intensive care unit. Acta Paediatr. 2004;93:205–210
  42. Lehmann OJ, Roberts CJ, Ikram K, et al. Association between nonadministration of subconjunctival cefuroxime and postoperative endophthalmitis. J Cataract Refract Surg. 1997;23:889–893
  43. Gills JP. Filters and antibiotics in irrigating solution for cataract surgery. [letter] J Cataract Refract Surg. 1991;17:385
  44. Feys J, Salvanet-Bouccara A, Emond JP, Dublanchet A. Vancomycin prophylaxis and intraocular contamination during cataract surgery. J Cataract Refract Surg. 1997;23:894–897
  45. Price MO, Quillin C, Price FW. Effect of gatifloxacin ophthalmic solution 0.3% on human corneal endothelial cell density and aqueous humor gatifloxacin concentration. Curr Eye Res. 2005;30:563–567
  46. Callegan MC, Ramirez R, Kane ST, et al. Antibacterial activity of the fourth-generation fluoroquinolones gatifloxacin and moxifloxacin against ocular pathogens. Adv Ther. 2003;20:246–252
  47. Kim DH, Stark WJ, O'Brien TP, Dick JD. Aqueous penetration and biological activity of moxifloxacin 0.5% ophthalmic solution and gatifloxacin 0.3% solution in cataract surgery patients. Ophthalmology. 2005;112:1992–1996
  48. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract surgery; an evidence-based update. Ophthalmology. 2002;109:13–24
  49. Kowalski RP, Romanowski EG, Mah FS, et al. Topical prophylaxis with moxifloxacin prevents endophthalmitis in a rabbit model. Am J Ophthalmol. 2004;138:33–37
  50. Costello P, Bakri SJ, Beer PM, et al. Vitreous penetration of topical moxifloxacin and gatifloxacin in humans. Retina. 2006;26:191–195
  51. McCulley JP, Caudle D, Aronowicz JD, Shine WE. Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. Ophthalmology. 2006;113:955–959
  52. Ulualp K, Condon RE. Antibiotic prophylaxis for scheduled operative procedures. Infect Dis Clin North Am. 1992;6(3):613–625
  53. Hwang DG. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol. 2004;49(suppl 2):S79–S83
  54. Deramo VA, Lai JC, Fastenberg DM, Udell IJ. Acute endophthalmitis in eyes treated prophylactically with gatifloxacin and moxifloxacin. Am J Ophthalmol. 2006;142:721–725
  55. Moshirfar M, Mirzaian G, Feiz V, Kang PC. Fourth-generation fluoroquinolone-resistant bacterial keratitis after refractive surgery. J Cataract Refract Surg. 2006;32:515–518
  56. Miller D, Flynn PM, Scott IU, et al. In vitro fluoroquinolone resistance in staphylococcal endophthalmitis isolates. Arch Ophthalmol. 2006;124:479–483

 The author has no financial or proprietary interest in any material or method mentioned.

PII: S0886-3350(07)02070-6

doi: 10.1016/j.jcrs.2007.11.027

Journal of Cataract & Refractive Surgery
Volume 34, Issue 3 , Pages 505-509 , March 2008

Article Tools